312-422-1111 [email protected]
  • Stay Updated
  • Become a Member
  • Business Solutions
  • iBIO Connect
  • Contact Us
iBIO
  • About
    • Introduction
    • Leadership
    • Contact
  • PROGRAMS
    • Overview
    • LabShare
    • STEMKits
    • StellarGirls
    • BioGENEius Illinois
  • Advocacy
    • Overview
    • Advocacy Center
    • Advocacy Toolkit
    • Rare Disease
  • News & Events
    • News
    • Events
    • Daily Newsletter
    • Walbert Award
  • Member Resources
    • Member Benefits
    • Business Solutions
    • Member Committees
    • Join iBIO
      • Discover our Community
  • Illinois Industry
    • About Illinois
    • Resource Map
    • State Incentives
Select Page
Chica­go’s biotech scene is grow­ing up. What’s fu­el­ing it?

Chica­go’s biotech scene is grow­ing up. What’s fu­el­ing it?

by John Conrad | Dec 18, 2024 | iBIO in the News

iBIO President & CEO John Conrad recently had the pleasure of chatting with Kyle LaHucik to discuss the exciting developments in our biotech ecosystem. Many of you may have already seen his excellent article published yesterday in Endpoints News, which provides a...
Chicago’s Quantum Leap: Pioneering the Future of Drug Discovery

Chicago’s Quantum Leap: Pioneering the Future of Drug Discovery

by John Conrad | Oct 16, 2024 | iBIO News

In the heart of the Midwest, a technological revolution is brewing that could transform the landscape of pharmaceutical research. Chicago, long known for its towering skyscrapers and deep-dish pizza, is now poised to become the epicenter of a quantum-powered...
FDA Grants Breakthrough Device Designation to Amphix Bio’s Bone Regeneration Product

FDA Grants Breakthrough Device Designation to Amphix Bio’s Bone Regeneration Product

by John Conrad | Oct 4, 2024 | Uncategorized

Chicago-based biotech company receives FDA recognition for innovative spinal implant In a significant development for the field of regenerative medicine, Amphix Bio announced on October 3, 2024, that it has received Breakthrough Device designation from the U.S. Food...
Chicago-based 32 Biosciences Emerges from Stealth Mode

Chicago-based 32 Biosciences Emerges from Stealth Mode

by John Conrad | Sep 11, 2024 | NewsBrief

In a significant development for the healthcare industry, Chicago-based 32 Biosciences has announced its emergence from stealth mode, unveiling a groundbreaking approach to gut microbiome medicine. The company, whose name is pronounced “Three Squared...
COUR Pharmaceuticals Names Dannielle Appelhans as New CEO

COUR Pharmaceuticals Names Dannielle Appelhans as New CEO

by John Conrad | Aug 5, 2024 | NewsBrief

COUR Pharmaceuticals, a clinical-stage biotech company focused on developing treatments for autoimmune and inflammatory diseases, has announced a significant leadership transition. Founder John J. Puisis will step down as President and Chief Executive Officer, handing...
« Older Entries
  • Home
  • About Us
  • Business Solutions
  • Advocacy
  • News
  • Join iBIO
  • Contact Us
  • Facebook
  • X
  • RSS
© 2022 iBIO | All Rights Reserved | Powered by BIRKEY.COM
X